-0.99%
240.83%
233.44%
81.82%
-52.83%
-85.38%
-89.69%
AI Spotlight on TOI
Company Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States.Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support.The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services.
It serves adult and senior cancer patients.The company operates 67 clinic locations.The Oncology Institute, Inc.
was founded in 2007 and is based in Cerritos, California.
Market Data
| Last Price | 1 |
| Change Percentage | -0.99% |
| Open | 1.01 |
| Previous Close | 1.01 |
| Market Cap ( Millions) | 76 |
| Volume | 1563300 |
| Year High | 2.19 |
| Year Low | 0.12 |
| M A 50 | 0.35 |
| M A 200 | 0.46 |
Financial Ratios
| FCF Yield | -49.65% |
| Dividend Yield | 0.00% |
| ROE | -176.71% |
| Debt / Equity | 794.15% |
| Net Debt / EBIDTA | -118.81% |
| Price To Book | 4.88 |
| Price Earnings Ratio | -1.2 |
| Price To FCF | -2.01 |
| Price To sales | 0.2 |
| EV / EBITDA | -2.38 |
News
- Dec -18 - Florida Blue enhances cancer care for thousands of members
- Nov -21 - Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
- Nov -14 - The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript
- Nov -08 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc.
- Nov -07 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc.
- Nov -06 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology
- Nov -05 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc.
- Nov -05 - The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
- Nov -04 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology
- Nov -01 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into The Oncology Institute, Inc.
- Oct -31 - Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the Third Quarter Ended September 30, 2024
- Oct -31 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc
- Oct -30 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc.
- Oct -29 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute Inc.
- Oct -28 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Partners, Inc.
- Oct -23 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc.
- Oct -23 - The Oncology Institute Joins Lantern's Cancer Care Network of Excellence
- Oct -22 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology
- Oct -16 - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology
- Oct -16 - Topicus.com Inc. Announces Release Date for Third Quarter Results
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Patient Services
Expected Growth : 8.4 %
What the company do ?
Patient Services from The Oncology Institute, Inc. provides comprehensive care and support to cancer patients, including treatment planning, symptom management, and emotional support.
Why we expect these perspectives ?
The Oncology Institute's 8.4% growth in Patient Services is driven by increasing demand for cancer care, expansion into new markets, and strategic partnerships. Additionally, advancements in precision medicine and immunotherapy have led to higher treatment volumes. Furthermore, the company's focus on patient-centric care and investment in digital health platforms have improved patient engagement and retention, contributing to the segment's growth.
Segment n°2 -> Dispensary
Expected Growth : 8.5 %
What the company do ?
The Dispensary from The Oncology Institute, Inc. is a patient-centric pharmacy providing oral oncolytic medications and personalized support to cancer patients.
Why we expect these perspectives ?
The Oncology Institute, Inc.'s dispensary growth of 8.5% is driven by increasing demand for cancer treatments, expansion into new markets, strategic partnerships, and improved patient outcomes. Additionally, the company's focus on personalized medicine, investment in digital health technologies, and growing acceptance of value-based care models contribute to its rapid growth.
Segment n°3 -> Clinical Trials & Other
Expected Growth : 10.5 %
What the company do ?
Clinical Trials & Other from The Oncology Institute, Inc. refers to innovative research studies and other initiatives focused on cancer treatment and care.
Why we expect these perspectives ?
The Oncology Institute's Clinical Trials & Other segment growth of 10.5% is driven by increasing demand for innovative cancer treatments, strategic partnerships with pharmaceutical companies, and expansion into new geographic markets. Additionally, investments in digital infrastructure and data analytics capabilities enhance patient recruitment and retention, further fueling growth.
The Oncology Institute, Inc. Products
| Product Range | What is it ? |
|---|---|
| Medical Oncology Services | Comprehensive cancer care services including chemotherapy, immunotherapy, and targeted therapy |
| Radiation Oncology Services | Advanced radiation therapy treatments, including external beam radiation therapy, stereotactic body radiation therapy, and brachytherapy |
| Surgical Oncology Services | Minimally invasive surgical procedures for cancer treatment, including laparoscopic and robotic-assisted surgery |
| Clinical Trials | Access to innovative and investigational cancer treatments through participation in clinical trials |
| Supportive Care Services | Comprehensive supportive care services, including nutrition counseling, pain management, and social work services |
| Genetic Counseling and Testing | Personalized genetic counseling and testing for hereditary cancer risk |
The Oncology Institute, Inc.'s Porter Forces
Threat Of Substitutes
The threat of substitutes is moderate for The Oncology Institute, Inc. due to the availability of alternative cancer treatment options, but the company's specialized services and strong reputation mitigate this threat.
Bargaining Power Of Customers
The bargaining power of customers is low for The Oncology Institute, Inc. as patients often rely on the company's specialized services and have limited negotiating power.
Bargaining Power Of Suppliers
The bargaining power of suppliers is moderate for The Oncology Institute, Inc. as the company relies on a few key suppliers for medical equipment and pharmaceuticals, but has some flexibility in its supply chain.
Threat Of New Entrants
The threat of new entrants is high for The Oncology Institute, Inc. due to the growing demand for cancer treatment services and the potential for new competitors to enter the market.
Intensity Of Rivalry
The intensity of rivalry is high for The Oncology Institute, Inc. due to the competitive nature of the cancer treatment services market and the presence of established competitors.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 62.05% |
| Debt Cost | 5.66% |
| Equity Weight | 37.95% |
| Equity Cost | 8.06% |
| WACC | 6.57% |
| Leverage | 163.49% |
The Oncology Institute, Inc. : Quality Control
The Oncology Institute, Inc. passed 3 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| CYH | Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal … |
| DCGO | DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; … |
| SNDA | Sonida Senior Living, Inc. develops, owns, operates, and manages senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational … |
| AONC | American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house … |
| BKD | Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
DocGo
A-Score
1-Year Total Return ->
🥈
Sonida Senior Living
A-Score
1-Year Total Return ->
🥉
Community Health Systems
A-Score
1-Year Total Return ->
4
American Oncology Network
A-Score
1-Year Total Return ->
5
Brookdale Senior Living
A-Score
1-Year Total Return ->
6
